72 related articles for article (PubMed ID: 19232321)
1. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2.
Chen Q; Dong L; Wang L; Kang L; Xu B
Biochem Biophys Res Commun; 2009 Apr; 381(2):192-7. PubMed ID: 19232321
[TBL] [Abstract][Full Text] [Related]
2. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract][Full Text] [Related]
3. Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications.
Benítez-Camacho J; Ballesteros A; Beltrán-Camacho L; Rojas-Torres M; Rosal-Vela A; Jimenez-Palomares M; Sanchez-Gomar I; Durán-Ruiz MC
Stem Cell Res Ther; 2023 Nov; 14(1):324. PubMed ID: 37950274
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes.
Bansal S; Burman A; Tripathi AK
World J Diabetes; 2023 Aug; 14(8):1146-1162. PubMed ID: 37664478
[TBL] [Abstract][Full Text] [Related]
5. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
[TBL] [Abstract][Full Text] [Related]
6. Advanced Glycation End Products Impair Cardiac Atrial Appendage Stem Cells Properties.
Evens L; Heeren E; Rummens JL; Bronckaers A; Hendrikx M; Deluyker D; Bito V
J Clin Med; 2021 Jul; 10(13):. PubMed ID: 34279448
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of advanced glycation end products inhibiting the proliferation of peripheral blood mononuclear cells and osteoblasts in rats].
Li Z; Wang X; Hong TP; Wang HJ; Gao ZY; Wan M
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 53(2):355-363. PubMed ID: 33879911
[TBL] [Abstract][Full Text] [Related]
8. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review.
Evens L; Beliën H; Deluyker D; Bronckaers A; Gervois P; Hendrikx M; Bito V
Stem Cells Int; 2020; 2020():8886612. PubMed ID: 33281904
[TBL] [Abstract][Full Text] [Related]
10. Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease.
Podkowińska A; Formanowicz D
Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32823917
[TBL] [Abstract][Full Text] [Related]
11. The Functionality of Endothelial-Colony-Forming Cells from Patients with Diabetes Mellitus.
Lyons CJ; O'Brien T
Cells; 2020 Jul; 9(7):. PubMed ID: 32698397
[TBL] [Abstract][Full Text] [Related]
12. Uremic Toxins and Vascular Dysfunction.
Six I; Flissi N; Lenglet G; Louvet L; Kamel S; Gallet M; Massy ZA; Liabeuf S
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32570781
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease.
Dou L; Jourde-Chiche N
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31590361
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential.
Pyšná A; Bém R; Němcová A; Fejfarová V; Jirkovská A; Hazdrová J; Jude EB; Dubský M
Stem Cell Rev Rep; 2019 Apr; 15(2):157-165. PubMed ID: 30413930
[TBL] [Abstract][Full Text] [Related]
15. Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis.
Yamagishi SI; Matsui T
Ann Vasc Dis; 2018 Sep; 11(3):253-258. PubMed ID: 30402172
[TBL] [Abstract][Full Text] [Related]
16. Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients.
De Ciuceis C; Agabiti-Rosei C; Rossini C; Caletti S; Coschignano MA; Ferrari-Toninelli G; Ragni G; Cappelli C; Cerudelli B; Airò P; Scarsi M; Tincani A; Porteri E; Rizzoni D
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):369-378. PubMed ID: 30203268
[TBL] [Abstract][Full Text] [Related]
17. Chronic Exposure of Human Endothelial Progenitor Cells to Diabetic Condition Abolished the Regulated Kinetics Activity of Exosomes.
Hassanpour M; Cheraghi O; Brazvan B; Hiradfar A; Aghamohammadzadeh N; Rahbarghazi R; Nouri M
Iran J Pharm Res; 2018; 17(3):1068-1080. PubMed ID: 30127829
[TBL] [Abstract][Full Text] [Related]
18. Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes.
Zhang H; Liu J; Qu D; Wang L; Wong CM; Lau CW; Huang Y; Wang YF; Huang H; Xia Y; Xiang L; Cai Z; Liu P; Wei Y; Yao X; Ma RCW; Huang Y
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6927-E6936. PubMed ID: 29967177
[TBL] [Abstract][Full Text] [Related]
19. Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy.
Kawamura M; Paulsen MJ; Goldstone AB; Shudo Y; Wang H; Steele AN; Stapleton LM; Edwards BB; Eskandari A; Truong VN; Jaatinen KJ; Ingason AB; Miyagawa S; Sawa Y; Woo YJ
Cardiovasc Diabetol; 2017 Nov; 16(1):142. PubMed ID: 29096622
[TBL] [Abstract][Full Text] [Related]
20. Soluble Receptor for Advanced Glycation End Products Improves Stromal Cell-Derived Factor-1 Activity in Model Diabetic Environments.
Olekson MP; Faulknor RA; Hsia HC; Schmidt AM; Berthiaume F
Adv Wound Care (New Rochelle); 2016 Dec; 5(12):527-538. PubMed ID: 28078186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
